ArticleActa pharmacologica Sinica2015

Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.

Ji-chao Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.